期刊文献+

血流动力学和氧动力学指标对严重感染患者预后的预测价值 被引量:4

下载PDF
导出
摘要 目的评估血流动力学、氧动力学指标对严重感染性患者预后的预测价值。方法将我院2007—2009年3月收住重症监护病房的68例严重感染患者,以是否存活分为存活组与死亡组,对所有患者常规采用早期液体复苏等集束化治疗措施,测定治疗前、治疗24h时血流动力学、氧动力学、血乳酸水平以及急性生理学及慢性健康状况Ⅱ评分(APACHEⅡ),比较两组间各指标的差异。结果入院时两组患者APACHEⅡ、心脏指数(CI)、血乳酸水平间差异有统计学意义(P<0.05);治疗24h时两组APACHEⅡ、CI、射血分数(EF)、氧输送(DO2)、氧消耗(VO2)、混合静脉血氧饱和度(SvO2)、平均动脉压(MAP)水平间差异均有统计学意义(P<0.05);两组患者MAP、中心静脉压(CVP)、红细胞百分比(Hct)间比较差异均无统计学意义(P>0.05)。结论APACHEⅡ、CI、血乳酸水平影响患者预后;血乳酸、SvO与DO可作为判断严重感染及其相关的感染性休克患者预后的良好指标。
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第6期665-667,共3页 Chinese General Practice
  • 相关文献

参考文献23

  • 1Kochanek KD, Murphy SI,, Anderson RN, et al. Deaths: final data for 2002 [ J] . Natl Vital Stat Rep, 2004, 53 (5): 1 -115.
  • 2Angusd C, Linde- zwirble WT, Lidickerj, et al.Epidemiology of severe sepsisin the United States: analysisof incidenee, outcome, andassoeiated costsof care [J ] . Cril Care Med, 2001, 29 (7): 1303-1310.
  • 3姚咏明,林洪远.严重感染与多器官功能障碍综合征[J].中国全科医学,2008,11(12):1025-1026. 被引量:23
  • 4Dellinger RP, Carletj M, Masur H, et ah Surviving sepsis campaign guidelines for management of severe sepsis and septic shock [J]. CritCareMed, 2004, 32 (6): 858- 872.
  • 5Hollenberg SM, AhrensTS, Annane D, et al. 2004 Practice parameters tor hemodynamic support of sepsis in adult patients: 2004 update [J]. Crit Care Med, 2004, 32 (9): 1928 - 1948.
  • 6于凯江,马晓春,刘大为,许媛,安友仲,汤耀卿,邱海波,严静,管向东.成人严重感染与感染性休克血流动力学监测与支持指南(草案)[J].医学与哲学(B),2006,27(12):20-28. 被引量:13
  • 7郭翼华,项嘉亮,陈荣策.血清降钙素原对感染性休克的诊断价值[J].中国基层医药,2005,12(5):590-590. 被引量:6
  • 8Winslow EJ, Loeb HS, Rahimtoola SH, et al. Hemodynamic studies and results of therapy in 50 patients with bacteremic shock [ J ]. AmJ Med, 1973, 54 (4): 421 -432.
  • 9Krausz MM, Perel A, Eimerl D, et al. Cardiopulmonary effects of volume loading in patients with septic shock [ J ] .Ann Surg, 1977, 185 (4): 429- 434.
  • 10Balk RA. Pathogencsis and management of multiple organ dysfunction or failure in severe sepsis and septic shock [ J ] . Crit Care Clin, 2000, 16 (2): 337-352.

二级参考文献29

  • 1杨毅,邱海波.《2004严重感染和感染性休克治疗指南》系列讲座(4) 糖皮质激素在感染性休克中的应用[J].中国危重病急救医学,2004,16(10):582-584. 被引量:12
  • 2慢性阻塞性肺疾病急性加重患者机械通气指南(2007)[J].中华急诊医学杂志,2007,16(4):350-357. 被引量:244
  • 3Mutschler DK, Eriksson MB, Wikstrom BG, et al. Microdialysisevaluated myocardial cyclooxygenase-mediated inflammation and early circulatory depression in porcine endotoxemia [ J ]. Crit Care Med, 2003, 31(6) :1780 -1785.
  • 4Singer M, De Santis V, Vitale D, et al. Muhiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation [ J ]. Lancet, 2004, 364 (9433) : S45 - S48.
  • 5Levy RJ, Vijayasarathy C, Raj NR, et al. Competitive and noncompetitive inhibition of myocardial cytochrome C oxidase in sepsis [ J]. Shock, 2004, 21 (2) :110 - 114.
  • 6Jia L,Takahashi M, Morimoto H, et al. Changes in cardiac lipid metabolism during sepsis: the role of very low-density lipoprotein receptors[ J ]. Cardiovasc Res, 2006, 69 (2) :545 - 555,
  • 7Mink SN, Jacobs H, Bose D, et al. Lysozyme: a mediator of myocardial depression and adrenergic dysfunction in septic shock in dogs [J]. J Mol Cell Cardiol, 2003, 35(3):265 -275.
  • 8Tavener SA, Long EM, Robbins SM, et al. Immune cell Toll-like receptor4 is required for cardiac myocyte impairment during endotoxemia[J]. Circ Res, 2004, 95(7) :700 -707.
  • 9Thomas JA, Haudek SB, Koroglu T, et al. IRAKI deletion disrupts cardiac TolI/IL-I signaling and protects against contractile dysfunction [ J ]. Am J Physiol Heart Circ Physiol, 2003, 285 ( 2 ) : H597 - H606.
  • 10Comini L, Boraso A, Bachetti T, et al. Effects od endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes[ J]. Pharmacol Res, 2005, 51 (5) :409 - 417.

共引文献56

同被引文献67

  • 1季大玺,龚德华.连续性血液净化在全身炎症反应综合征和多器官功能不全综合征中的应用[J].临床外科杂志,2004,12(11):659-660. 被引量:19
  • 2齐志伟,王仲,梁璐,徐军,朱华栋,李毅,于学忠,马遂.全心舒张末容量作为判定心脏前负荷指标在犬失血性休克模型中的研究[J].中国急救医学,2006,26(5):360-362. 被引量:12
  • 3中华医学会心血管病分会 中华心血管病杂志编委会 中国心肌病诊断与治疗建议工作组.全国心肌炎心肌病学术研讨会纪要.中华心血管病杂志,1999,6(1):3-16.
  • 4Kalantar-Zadeh K,Anker SD,Horwich TB,et al.Nutritional and anti-inflammatory interventions in chronic heart failure.[J].Am J Cardiol,2008,101(11A):89E-103E.
  • 5Krack A,Sharma R,Figulla HR,et al.The important of the gastrointestinal system in the pathogenesis of heart failure[J].Eur Heart J,2005,26(22):2368-2374.
  • 6Voigt A,Bartel K,Egerer K,et al.Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy[J].Basic Res Cardiol,2010,105(1):9-18.
  • 7Toshinari T,Takayoshi T,Keizo N,et al.Impact of oxidative stress on plasma adiponectin in patients with chronic heart failure[J].Circ J,2008,72(5):563-568.
  • 8Santiago R,Antoni BG.Vascular dysfunction in idiopathic dilated cardiomyopathy[J].Nat Rev Cardiol,2009,6(9):590-598.
  • 9Grunfeld C,Feingold KR.HDL and innate immunity:a tale of two apolipoproteins[J].J Lipid Res,2008,49(8):1605-1606.
  • 10Gotto AM Jr.Role of C-reactive protein in coronary risk reduction:focus on primary prevention[J].Am J Cardiol,2007,99(5):718-725.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部